Cancer iChart 12+

Name: Cancer iChart
Author: Liverpool Drug Interactions Group

Liverpool Drug Interactions Group

Progettata per iPad

- Gratis

Descrizione

Healthcare professionals and patients should use this application to search for potential drug-drug interactions between anti-cancer drugs and other medications. Results are presented as a “Traffic Light” system (red, amber, yellow and green) to indicate the recommendation. A brief summary of each interaction is given along with a grading of the quality of evidence (very low, low, moderate, high). The application is available free of charge and has been developed by Radboudumc in Nijmegen, the Liverpool Drug Interactions Group at the University of Liverpool and Clubzap Ltd.

Requirements: This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates.  

Why this application may be useful:
Patients with cancer often take medication in addition to cancer therapy either to aid side effects and symptoms, or to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different anti-cancer drugs and other medications that the cancer patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.cancer-druginteractions.org

1 nov 2023

Versione 1.0.1

- Minor updates around archiving of website.

Lo sviluppatore, Liverpool Drug Interactions Group, ha indicato che le procedure per la tutela della privacy dell’app potrebbero includere il trattamento dei dati descritto di seguito. Per ulteriori informazioni, consulta l’informativa sulla privacy dello sviluppatore.